DE69019375D1 - Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren. - Google Patents

Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.

Info

Publication number
DE69019375D1
DE69019375D1 DE69019375T DE69019375T DE69019375D1 DE 69019375 D1 DE69019375 D1 DE 69019375D1 DE 69019375 T DE69019375 T DE 69019375T DE 69019375 T DE69019375 T DE 69019375T DE 69019375 D1 DE69019375 D1 DE 69019375D1
Authority
DE
Germany
Prior art keywords
biological fluids
humans
animals
bone
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69019375T
Other languages
English (en)
Other versions
DE69019375T2 (de
Inventor
Simon Robins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rowett Research Institute
Original Assignee
Rowett Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowett Research Institute filed Critical Rowett Research Institute
Publication of DE69019375D1 publication Critical patent/DE69019375D1/de
Application granted granted Critical
Publication of DE69019375T2 publication Critical patent/DE69019375T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Window Of Vehicle (AREA)
  • Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69019375T 1989-12-30 1990-12-28 Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren. Expired - Fee Related DE69019375T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898929366A GB8929366D0 (en) 1989-12-30 1989-12-30 Method to detect connective tissue disorder in humans and animals
PCT/GB1990/002030 WO1991010141A1 (en) 1989-12-30 1990-12-28 Method to detect bone and other connective tissue disorders in humans and animals

Publications (2)

Publication Number Publication Date
DE69019375D1 true DE69019375D1 (de) 1995-06-14
DE69019375T2 DE69019375T2 (de) 1995-09-14

Family

ID=10668604

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69019375T Expired - Fee Related DE69019375T2 (de) 1989-12-30 1990-12-28 Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.
DE69033511T Expired - Lifetime DE69033511T2 (de) 1989-12-30 1990-12-28 Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69033511T Expired - Lifetime DE69033511T2 (de) 1989-12-30 1990-12-28 Verfahren zum Nachweis von Knochen- und anderen Bindegewebeerkrankungen in Menschen und Tieren

Country Status (17)

Country Link
US (2) US5700693A (de)
EP (2) EP0507831B1 (de)
JP (3) JPH087212B2 (de)
KR (1) KR0138503B1 (de)
AT (2) ATE122467T1 (de)
AU (2) AU648774B2 (de)
BR (1) BR9007969A (de)
CA (2) CA2069611C (de)
DE (2) DE69019375T2 (de)
DK (1) DK0507831T3 (de)
ES (2) ES2147761T3 (de)
FI (1) FI923028A (de)
GB (1) GB8929366D0 (de)
GR (1) GR3016998T3 (de)
HU (1) HUT64421A (de)
NO (1) NO304760B1 (de)
WO (1) WO1991010141A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121002A (en) * 1990-12-26 2000-09-19 The Rowett Research Institute Method to detect bone and other connective tissue disorders in humans and animals
GB9202139D0 (en) * 1992-01-31 1992-03-18 Sandoz Ltd Improvements in or relating to organic compounds
DE69321503T2 (de) * 1992-03-19 1999-05-06 Hoechst Marion Roussel Ltd Gewebeantigen und seine Anwendung in einem Nachweisverfahren von humaner Osteoporose
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5527715A (en) * 1992-07-31 1996-06-18 Metra Biosystems, Inc. Method and kit for pyridinoline assay
WO1994006015A1 (en) * 1992-08-28 1994-03-17 The Rowett Research Institute Method to monitor drug therapy and assess metastasis
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
JPH0792165A (ja) * 1993-09-21 1995-04-07 Hoechst Japan Ltd 骨粗鬆症診断剤
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
ES2214722T3 (es) * 1997-07-31 2004-09-16 Metra Biosystems, Inc. Metodo de ensayo de peptidos de colageno.
US6033918A (en) * 1997-11-10 2000-03-07 Bayer Corporation Method and device for the detection of analyte in a fluid sample
AU3035699A (en) * 1998-03-27 1999-10-18 Seibel, Markus Determination of the probability of bone metastases in patients with primary carcinomas
US6197592B1 (en) * 1999-07-15 2001-03-06 Bio-Rad Laboratories, Inc. Clinical control materials for detection of bone resorptive markers
EP1325339A2 (de) * 2000-10-03 2003-07-09 The Rowett Research Institute Verfahren zur bestimmung von pyrrol-enthaltenden biologischen substanzen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
US5283197A (en) * 1988-06-25 1994-02-01 The Rowett Research Institute Method of monitoring collagen degradation
GB8927377D0 (en) * 1989-12-04 1990-01-31 Univ Edinburgh Improvements in and relating to amperometric assays
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
FI106326B (fi) * 1996-09-23 2001-01-15 Tellabs Oy Kytkentä kaiunpoistavan moninopeusmodeemin sovittamiseksi linjalle sekä kytkentämenetelmä

Also Published As

Publication number Publication date
US5700694A (en) 1997-12-23
NO922573D0 (no) 1992-06-29
CA2069611C (en) 1999-08-10
EP0507831A1 (de) 1992-10-14
AU682188B2 (en) 1997-09-25
ES2071979T3 (es) 1995-07-01
EP0618448B1 (de) 2000-04-19
DE69033511D1 (de) 2000-05-25
JP2001050958A (ja) 2001-02-23
GB8929366D0 (en) 1990-02-28
AU648774B2 (en) 1994-05-05
CA2271544A1 (en) 1991-07-01
GR3016998T3 (en) 1995-11-30
HUT64421A (en) 1993-12-28
CA2271544C (en) 2006-01-17
EP0507831B1 (de) 1995-05-10
KR0138503B1 (en) 1998-05-15
DE69019375T2 (de) 1995-09-14
DE69033511T2 (de) 2000-11-16
CA2069611A1 (en) 1991-07-01
JPH087212B2 (ja) 1996-01-29
ATE122467T1 (de) 1995-05-15
EP0618448A1 (de) 1994-10-05
WO1991010141A1 (en) 1991-07-11
HU9202178D0 (en) 1992-10-28
BR9007969A (pt) 1993-02-02
DK0507831T3 (da) 1995-10-09
JP3224356B2 (ja) 2001-10-29
FI923028A0 (fi) 1992-06-30
ES2147761T3 (es) 2000-10-01
JPH1045800A (ja) 1998-02-17
AU7065991A (en) 1991-07-24
US5700693A (en) 1997-12-23
JPH05502942A (ja) 1993-05-20
NO922573L (no) 1992-06-29
NO304760B1 (no) 1999-02-08
ATE191976T1 (de) 2000-05-15
FI923028A (fi) 1992-06-30
AU6864894A (en) 1994-11-24

Similar Documents

Publication Publication Date Title
DE69019375T2 (de) Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.
ATE455554T1 (de) Verfahren zur erhöhung der mageren fleischmasse mit fettleibigkeitsprotein (ob) zusammensetzungen
DE68918103T2 (de) Verfahren zur überwachung des kollagenabbaus.
ES2071778T3 (es) Equivalentes de tejidos vivos.
DE69029257T2 (de) Anordnung zur bestrahlung von laserstrahlen
DE69226548D1 (de) Verfahren zum Nachweis des Abbaus von Typ-I-Kollagen
DE69821246D1 (de) Testverfahren für collagenpeptid
DE69230000T2 (de) Verfahren und testsatz zur messung von endogenen zytokinen
ATE347697T1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
DE69204157T2 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ATE352039T1 (de) Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
DE3850728T2 (de) Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.
DE68920477T2 (de) Verfahren zur Diagnose von Tumoren.
DE69734890D1 (de) Rdgb-proteine
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
DE60311278D1 (de) Immunochromatographiesystem und verfahren zur gleichzeitigen identifikation von aga-und t-tg-antikörpern und verwendung dafür zur diagnose der zöliakiekrankheit
DE3778375D1 (de) Reagenzsatz, seine verwendung und diagnostisches verfahren zur bestimmung von humanen pankreasspezifischen proteinen.
ATE45271T1 (de) Mittel und verfahren zur optimierung der gewebemasse von organen innerhalb der genetischen schwankungsbreite bei menschen und tieren.
ATE75050T1 (de) Reagenzsatz, seine verwendung und diagnostisches verfahren zur bestimmung von humanen pankreasspezifischen proteinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee